Clinical Management of Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, Roberto Rodriguez-Roisin, Gerard Huchon, Nicolas Roche

• PART I: UNDERSTANDING COPD AND ITS IMPACT. 2.Smoking Cessation. 3. The Relationship of Tobacco Smoking to COPD: Histopathogenesis. 4. COPD as a Systemic Disease. PART II: ASSESSING COPD. 5. Early Diagnosis of COPD: Usefulness, Tools, and Actors. 6. Assessment of Symptoms and Quality of Life in the.COPD Patient. 7. Measuring Ventilatory and Respiratory Impairment in COPD. 8. Imaging of Lung Morphology and Function in COPD. 9. Assessing the Systemic Consequences of COPD. 10. The Pulmonary Vasculature of COPD. 11. How the COPD Patient Should Be Assessed for Comorbidities .12. Goals of COPD Treatments and Measurement of Their Efficacy: From Clinical Trials to Real-World Practice. PART III: PHARMACOLOGICAL TREATMENTS OF COPD. 13. Choosing the Right Bronchodilator. 14. When Should We Use Glucocorticoids in COPD? 15. Treating and Preventing Infections. 16. Phosphodiesterase 4 Inhibitors, Mucolytics, and Emerging Pharmacotherapies for COPD. 17. Managing Exacerbations: An Overview. PART IV: NONPHARMACOLOGICAL APPROACHES IN COPD. 18. Exercise Training in COPD. 19. New Components of Pulmonary Rehabilitation in COPD. 20. Long-Term Oxygen Therapy for the Patient with COPD. 21. Noninvasive Ventilation in COPD. 22. Surgical Therapy for COPD. 23. Perioperative Medical Management for Patients with COPD: The Anesthesiologist’s View. 24. Providing Palliative and End-of-Life Care for Patients.with COPD. PART V: CONCLUSION. 25. A Global Strategy for a Global Disease. 26. Caring for the Patient with COPD: A Practical Summary of Guidelines for Clinicians